Suven Life Sciences Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 2 October 2026, 9:36 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price308₹ per share
Reported P/ENot availableTimes
Book value per share22.4₹ per share
Reported ROCE79.5 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 2 October 2026, 9:36 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap8,711 Cr.
Current Price308
High / Low403/124
Stock P/ENot available
Book Value22.4
Dividend Yield0.00 %
ROCE79.5 %
ROE81.5 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Suven Life Sciences Ltd 8,711 Cr. 308 403/124 22.40.00 %79.5 %81.5 % 1.00
Sequent Scientific Ltd 8,768 Cr. 201 260/111203 32.20.00 %8.47 %3.21 % 2.00
Aarti Pharmalabs Ltd 8,782 Cr. 968 1,002/58440.8 2340.36 %10.7 %8.59 % 5.00
Procter & Gamble Health Ltd 8,897 Cr. 5,360 6,975/4,70026.7 3162.89 %83.9 %61.9 % 10.0
Morepen Laboratories Ltd 7,327 Cr. 134 135/33.062.4 22.80.15 %8.05 %5.33 % 2.00
Industry Average17,573.63 Cr1,250.1655.08211.240.39%26.16%16.59%6.06

All Competitor Stocks of Suven Life Sciences Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 4322132121324
Expenses 3227493332554145538110652136
Operating Profit -28-24-46-30-31-52-39-44-51-80-103-51-132
OPM % -737%-768%-1,885%-1,267%-3,024%-2,032%-2,435%-2,981%-2,714%-8,671%-3,678%-3,331%-3,711%
Other Income 61364442114378
Interest 0000000-0-0-0-000
Depreciation 2222112111122
Profit before tax -24-13-42-28-28-50-39-44-52-77-102-46-128
Tax % -0%-0%-0%-4%-0%-0%-0%-0%-0%-0%-0%-0%-0%
Net Profit -24-13-42-27-28-50-39-44-52-77-102-46-128
EPS in Rs -1.10-0.58-1.91-1.22-1.29-2.28-1.79-2.01-2.36-3.40-4.48-1.73-4.83

Last Updated: October 4, 2026, 9:52 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 4, 2026, 9:52 pm

MetricMar 2008Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 1175214995436252861313121412779
Expenses 10536139841442730012893134139140172291375
Operating Profit 13159102129198-14-116-80-122-126-128-166-284-366
OPM % 11%31%20%24%32%-5%-917%-593%-1,032%-929%-1,094%-2,487%-3,999%-4,152%
Other Income 391921232714851429111421
Interest 55665211100001
Depreciation 4121821211144476666
Profit before tax 6152981231960-106-77-122-118-106-161-276-352
Tax % -32%28%26%29%37%15,038%-11%-7%-0%-0%-1%-0%-0%
Net Profit 81097287124-24-94-72-122-118-105-161-276-352
EPS in Rs 0.485.703.764.576.48-1.25-4.94-3.78-5.59-5.42-4.82-7.37-10.48-14.44
Dividend Payout % 35%7%35%15%15%-80%-0%-0%-0%-0%-0%-0%-0%

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)-33.94%20.83%42.53%-119.35%-291.67%23.40%-69.44%3.28%11.02%-53.33%-71.43%
Change in YoY Net Profit Growth (%)0.00%54.78%21.70%-161.88%-172.31%315.07%-92.85%72.72%7.74%-64.35%-18.10%

Suven Life Sciences Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2015-2016 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:-35%
5 Years:-12%
3 Years:-17%
TTM:-16%
Compounded Profit Growth
10 Years:Not available
5 Years:-24%
3 Years:-12%
TTM:-58%
Stock Price CAGR
10 Years:32%
5 Years:36%
3 Years:43%
1 Year:40%
Return on Equity
10 Years:-13%
5 Years:-62%
3 Years:-55%
Last Year:-87%

Last Updated: September 5, 2025, 1:41 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 4, 2026, 9:52 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 131313131313131522222226
Reserves 547583654755226131958235424888565
Borrowings 109837134365321-017
Other Liabilities 1057478118623316912142516
Total Liabilities 773751816919303182128108389285135624
Fixed Assets 1723053063082225213837286073
CWIP 107710250-054-0-004
Investments 003012792230045467622181
Other Assets 494439199308581571032230518153367
Total Assets 773751816919303182128108389285135624
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 1436810970-53-135-96-128-116-115-155-300
Cash from Investing Activity + -110-39-311-13014656-22-24894155-462
Cash from Financing Activity + 179-68-30-525335146396-1-1757
Net Cash Flow 212-39-23217-1814-5-432-22-1-5
Free Cash Flow 25107928-92-137-102-147-119-113-193-305
CFO/OP 113%93%111%57%262%114%119%104%91%95%93%106%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow25.0010.0079.0028.00-92.00-137.00-102.00-147.00-119.00-113.00-193.00-305.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2008Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 111283931363664840224073
Inventory Days 2001651832223290
Days Payable 157897891134
Cash Conversion Cycle 1541051441622313664840224073
Working Capital Days 13949554282237041,084234265101-440
ROCE %8%13%15%24%-4%-54%-58%-118%-53%-36%-87%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Jul 2026
Promoters 69.56%69.56%70.26%70.26%70.26%70.26%70.26%67.36%67.36%70.15%70.08%65.47%
FIIs 0.54%0.46%0.45%0.33%0.34%0.25%0.58%1.17%1.07%0.91%0.56%0.48%
DIIs 0.01%1.05%1.05%1.05%1.05%0.01%0.03%3.39%3.39%4.62%2.93%2.73%
Public 29.88%28.91%28.21%28.34%28.35%29.47%29.12%28.07%28.18%24.32%26.42%31.32%
No. of Shareholders 74,00368,95966,11663,97563,53764,60366,15964,92164,38163,91566,79166,647
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 6,121,393 4.44 295.826,081,3732026-06-11 06:07:180.66%
Invesco India Contra Fund 4,013,973 1 193.983,598,5112026-06-11 06:07:1811.55%
DSP ELSS Tax Saver Fund 3,285,254 0.97 158.76N/AN/AN/A
DSP Healthcare Fund 3,140,630 4.83 151.772,972,2132026-06-11 06:07:185.67%
DSP Aggressive Hybrid Fund 2,808,197 1.17 135.71N/AN/AN/A
DSP Large & Mid Cap Fund 2,762,648 0.77 133.51N/AN/AN/A
DSP Flexi Cap Fund 2,453,891 1.01 118.58N/AN/AN/A
ICICI Prudential India Opportunities Fund 2,377,398 0.32 114.89N/AN/AN/A
Bandhan Small Cap Fund 2,331,139 0.44 112.652,160,1392026-03-23 09:32:117.92%
ICICI Prudential Value Fund 2,301,367 0.19 111.213,263,0912026-06-11 06:07:18-29.47%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) -7.37-4.82-6.63-9.57-5.67
Diluted EPS (Rs.) -7.37-4.82-6.63-9.57-5.67
Cash EPS (Rs.) -7.10-4.52-5.12-8.09-5.33
Book Value[Excl.RevalReserv]/Share (Rs.) 5.0412.3817.216.618.49
Book Value[Incl.RevalReserv]/Share (Rs.) 5.0412.3817.216.618.49
Revenue From Operations / Share (Rs.) 0.300.530.620.811.06
PBDIT / Share (Rs.) -7.10-4.90-5.39-8.05-5.68
PBIT / Share (Rs.) -7.37-5.20-5.69-8.35-6.02
PBT / Share (Rs.) -7.37-4.86-5.42-8.39-6.09
Net Profit / Share (Rs.) -7.37-4.82-5.42-8.39-5.67
NP After MI And SOA / Share (Rs.) -7.37-4.82-5.42-8.39-5.67
PBDIT Margin (%) -2326.94-914.01-867.37-988.42-536.50
PBIT Margin (%) -2414.41-969.62-915.70-1025.51-568.75
PBT Margin (%) -2415.11-907.20-873.52-1029.98-574.80
Net Profit Margin (%) -2415.11-898.63-873.52-1029.98-535.31
NP After MI And SOA Margin (%) -2415.11-898.63-873.52-1029.98-535.31
Return on Networth / Equity (%) -146.14-38.91-31.51-126.88-66.80
Return on Capital Employeed (%) -143.86-41.77-32.81-121.80-68.13
Return On Assets (%) -118.90-36.88-30.41-112.92-56.18
Total Debt / Equity (X) 0.000.000.000.010.00
Asset Turnover Ratio (%) 0.030.030.020.030.04
Current Ratio (X) 3.2118.9922.618.016.45
Quick Ratio (X) 3.2018.9422.618.016.45
Inventory Turnover Ratio (X) 14.070.000.000.000.00
Interest Coverage Ratio (X) -3323.53-674.71-406.21-220.85-88.68
Interest Coverage Ratio (Post Tax) (X) -3448.46-709.43-428.84-229.14-87.49
Enterprise Value (Cr.) 2435.232010.22872.721343.38849.81
EV / Net Operating Revenue (X) 365.88171.9264.46113.4263.05
EV / EBITDA (X) -15.72-18.81-7.43-11.47-11.75
MarketCap / Net Operating Revenue (X) 371.55185.9478.07113.8566.48
Price / BV (X) 22.488.052.8214.028.30
Price / Net Operating Revenue (X) 371.56185.9778.08113.8566.48
EarningsYield -0.06-0.04-0.11-0.09-0.08
Advertisements